{
    "id": "52625245",
    "公司名稱": "安立璽榮生醫股份有限公司",
    "資本總額(元)": "550,000,000",
    "實收資本額(元)": "473,880,000",
    "代表人姓名": "陳_愷",
    "公司所在地": "臺北市南港區忠孝東路7段508號16樓之3",
    "登記機關": "臺北市政府",
    "核准設立日期": {
        "year": 2017,
        "month": 3,
        "day": 30
    },
    "最後核准變更日期": {
        "year": 2024,
        "month": 5,
        "day": 15
    },
    "所營事業資料": [
        [
            "IG01010",
            "生物技術服務業"
        ],
        [
            "IC01010",
            "藥品檢驗業"
        ],
        [
            "IG02010",
            "研究發展服務業"
        ],
        [
            "F601010",
            "智慧財產權業"
        ],
        [
            "F107070",
            "動物用藥品批發業"
        ],
        [
            "F207070",
            "動物用藥零售業"
        ],
        [
            "F401010",
            "國際貿易業"
        ],
        [
            "I103060",
            "管理顧問業"
        ],
        [
            "ZZ99999",
            "除許可業務外，得經營法令非禁止或限制之業務"
        ]
    ],
    "董監事名單": [
        {
            "序號": "0001",
            "職稱": "董事長",
            "姓名": "陳_愷",
            "所代表法人": [
                0,
                "英屬開曼群島商 Elixiron Immunotherapeutics (Cayman) Limited"
            ],
            "出資額": "47,388,000"
        },
        {
            "序號": "0002",
            "職稱": "董事",
            "姓名": "顧_崙",
            "所代表法人": [
                0,
                "英屬開曼群島商 Elixiron Immunotherapeutics (Cayman) Limited"
            ],
            "出資額": "47,388,000"
        },
        {
            "序號": "0003",
            "職稱": "董事",
            "姓名": "莊_嘉",
            "所代表法人": [
                0,
                "英屬開曼群島商 Elixiron Immunotherapeutics (Cayman) Limited"
            ],
            "出資額": "47,388,000"
        }
    ],
    "經理人名單": [],
    "股權狀況": "僑外資",
    "章程所訂外文公司名稱": "ELIXIRON IMMUNOTHERAPEUTICS INC.",
    "複數表決權特別股": "無",
    "對於特定事項具否決權特別股": "無",
    "每股金額(元)": "10",
    "已發行股份總數(股)": "47,388,000",
    "登記現況": "核准設立"
}